Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Top Cited Papers
Open Access
- 5 February 2019
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 92 (6), e601-e612
- https://doi.org/10.1212/wnl.0000000000006875
Abstract
Objective To examine the cross-sectional associations between regional tau, β-amyloid (Aβ), and cortical thickness and neuropsychological function across the preclinical and clinical spectrum of Alzheimer disease (AD). Methods We included 106 participants from the Swedish Biomarkers for Identifying Neurodegenerative Disorders Early and Reliably (BioFINDER) study, of whom 33 had preclinical AD (Aβ-positive cognitively normal individuals), 25 had prodromal AD (Aβ-positive mild cognitive impairment), and 48 had probable AD dementia. All underwent [18F]flortaucipir (tau) and structural MRI (cortical thickness), and 88 of 106 underwent [18F]flutemetamol (Aβ) PET. Linear regression models adjusted for age, sex, and education were performed to examine associations between 7 regions of interest and 7 neuropsychological tests for all 3 imaging modalities. Results In preclinical AD, [18F]flortaucipir, but not [18F]flutemetamol or cortical thickness, was associated with decreased global cognition, memory, and processing speed (range standardized β = 0.35–0.52, p < 0.05 uncorrected for multiple comparisons). In the combined prodromal AD and AD dementia group, both increased [18F]flortaucipir uptake and reduced cortical thickness were associated with worse performance on a variety of neuropsychological tests (most regions of interest survived correction for multiple comparisons at p < 0.05), while increased [18F]flutemetamol uptake was specifically associated with lower scores on a delayed recall memory task (p < 0.05 uncorrected for multiple comparisons). The strongest effects for both [18F]flortaucipir and cortical thickness on cognition were found in the lateral and medial parietal cortex and lateral temporal cortex. The effect of [18F]flutemetamol on cognition was generally weaker and less region specific. Conclusion Our findings suggest that tau PET is more sensitive than Aβ PET and measures of cortical thickness for detecting early cognitive changes in preclinical AD. Furthermore, both [18F]flortaucipir PET and cortical thickness show strong cognitive correlates at the clinical stages of AD.This publication has 50 references indexed in Scilit:
- Tau PET imaging predicts cognition in atypical variants of Alzheimer's diseaseHuman Brain Mapping, 2017
- Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s diseaseBrain, 2017
- Cognitive impairment and decline in cognitively normal older adults with high amyloid‐β: A meta‐analysisAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2016
- PET Imaging of Tau Deposition in the Aging Human BrainNeuron, 2016
- Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer’s diseaseBrain, 2015
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaThe Lancet Neurology, 2014
- The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s DiseaseNeuron, 2014
- Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvementBrain, 2012
- Face-name associative memory performance is related to amyloid burden in normal elderlyNeuropsychologia, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011